Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5387 ARTÍCULOS , VIENDO DEL 2716 AL 2730

The Use of Cannabis and Cannabinoids in Treating Symptoms of Multiple Sclerosis: a Systematic Review of Reviews

Nielsen S, Germanos R, Weier M, Pollard J, Degenhardt L, Hall W, Buckley N, Farrell M.

Curr Neurol Neurosci Rep. 2018 Feb 13;18(2):8. doi: 10.1007/s11910-018-0814-x.

Natural history of neurological abnormalities in cerebrotendinous xanthomatosis

Wong JC, Walsh K, Hayden D, Eichler FS.

J Inherit Metab Dis. 2018 Jul;41(4):647-656. doi: 10.1007/s10545-018-0152-9. Epub 2018 Feb 26.

Transient regional cerebral hypoperfusion during a paroxysmal hemiplegic event in GLUT1 deficiency syndrome

Almuqbil M, Rivkin MJ, Takeoka M, Yang E, Rodan LH.

Eur J Paediatr Neurol. 2018 May;22(3):544-547. doi: 10.1016/j.ejpn.2018.02.005. Epub 2018 Feb 19.

Novel homozygous GBA2 mutation in a patient with complicated spastic paraplegia

Coarelli G, Romano S, Travaglini L, Ferraldeschi M, Nicita F, Spadaro M, Fornasiero A, Frontali M, Salvetti M, Bertini E, Ristori G.

Clin Neurol Neurosurg. 2018 May;168:60-63. doi: 10.1016/j.clineuro.2018.02.042. Epub 2018 Mar 3.

Pontocerebellar hypoplasia type 1 for the neuropediatrician: Genotype-phenotype correlations and diagnostic guidelines based on new cases and overview of the literature

Ivanov I, Atkinson D, Litvinenko I, Angelova L, Andonova S, Mumdjiev H, Pacheva I, Panova M, Yordanova R, Belovejdov V, Petrova A, Bosheva M, Shmilev T, Savov A, Jordanova A.

Eur J Paediatr Neurol. 2018 Jul;22(4):674-681. doi: 10.1016/j.ejpn.2018.03.011. Epub 2018 Apr 3.

CAPN1 mutations broadening the hereditary spastic paraplegia/spinocerebellar ataxia phenotype

Lambe J, Monaghan B, Munteanu T, Redmond J.

Pract Neurol. 2018 Oct;18(5):369-372. doi: 10.1136/practneurol-2017-001842. Epub 2018 Apr 20.

Paroxysmal ocular movements - an early sign in Glut1 deficiency Syndrome

Reis S, Matias J, Machado R, Monteiro JP.

Metab Brain Dis. 2018 Aug;33(4):1381-1383. doi: 10.1007/s11011-018-0225-3. Epub 2018 May 5.

Trihexyphenidyl for dystonia in cerebral palsy

Harvey AR, Baker LB, Reddihough DS, Scheinberg A, Williams K.

Cochrane Database Syst Rev. 2018 May 15;5(5):CD012430. doi: 10.1002/14651858.CD012430.pub2.

Intrathecal Baclofen Therapy for Painful Muscle Spasms in a Patient with Friedreich's Ataxia

Kalyvas AV, Drosos E, Korfias S, Gatzonis S, Themistocleous M, Sakas DE.

Stereotact Funct Neurosurg. 2018;96(2):127-130. doi: 10.1159/000489220. Epub 2018 Jun 8.

Spastic ataxias

Bereznyakova O, Dupré N.

Handb Clin Neurol. 2018;155:191-203. doi: 10.1016/B978-0-444-64189-2.00012-3.

Drug treatment

Perlman S, Boltshauser E.

Handb Clin Neurol. 2018;155:371-377. doi: 10.1016/B978-0-444-64189-2.00024-X.

Novel mutations in the ALDH18A1 gene in complicated hereditary spastic paraplegia with cerebellar ataxia and cognitive impairment

Koh K, Ishiura H, Beppu M, Shimazaki H, Ichinose Y, Mitsui J, Kuwabara S, Tsuji S, Takiyama Y; Japan Spastic Paraplegia Research Consortium.

J Hum Genet. 2018 Sep;63(9):1009-1013. doi: 10.1038/s10038-018-0477-0. Epub 2018 Jun 18.

C-terminal proline deletions in KCNC3 cause delayed channel inactivation and an adult-onset progressive SCA13 with spasticity

Khare S, Galeano K, Zhang Y, Nick JA, Nick HS, Subramony SH, Sampson J, Kaczmarek LK, Waters MF.

Cerebellum. 2018 Oct;17(5):692-697. doi: 10.1007/s12311-018-0950-5.

Movement disorders in cerebrotendinous xanthomatosis

Stelten BML, van de Warrenburg BPC, Wevers RA, Verrips A.

Parkinsonism Relat Disord. 2019 Jan;58:12-16. doi: 10.1016/j.parkreldis.2018.07.006. Epub 2018 Jul 19.

The glucose transporter type 1 (Glut1) syndromes

Koch H, Weber YG.

Epilepsy Behav. 2019 Feb;91:90-93. doi: 10.1016/j.yebeh.2018.06.010. Epub 2018 Jul 31.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias